STANDARD BIOTOOLS INC. - COMMON STOCK

Standard BioTools Announces Conference Call and Webcast for Second Quarter 2024 Financial Results on July 31, 2024

17 Jul 2024 05:01:00 By Nasdaq GlobeNewswire

Standard BioTools Purchases the Carterra® LSA-XT System to Accelerate Data Delivery and Provide Greater Validation to SomaScan Customers

28 May 2024 13:01:00 By Nasdaq GlobeNewswire

Standard BioTools to Participate in Upcoming Investor Conferences

22 May 2024 13:01:00 By Nasdaq GlobeNewswire

Standard BioTools Inc. Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)

20 May 2024 05:00:00 By Nasdaq GlobeNewswire

Standard BioTools Reports First Quarter 2024 Financial Results

08 May 2024 13:01:00 By Nasdaq GlobeNewswire

Standard BioTools Announces Operational Restructuring Plan to Drive Long-Term Profitable Growth

25 Apr 2024 05:01:00 By Nasdaq GlobeNewswire

Standard BioTools Announces Conference Call and Webcast for First Quarter 2024 Financial Results on May 8, 2024

25 Apr 2024 05:00:00 By Nasdaq GlobeNewswire

Standard BioTools Introduces New High-Throughput Multiplexed Whole Slide Imaging Modalities Set to Redefine the boundaries of Tissue Imaging

08 Apr 2024 05:00:00 By Nasdaq GlobeNewswire

Standard BioTools Announces Multi-Year Strategic Engagement with Bristol Myers Squibb for Use of the SomaScan® Platform for Translational Medicine Research

03 Apr 2024 13:01:13 By Nasdaq GlobeNewswire

Standard BioTools Announces Exchange of All Outstanding Series B Convertible Preferred Stock for Common Stock

18 Mar 2024 05:12:23 By Nasdaq GlobeNewswire

Standard BioTools Reports Fourth Quarter and Full Year 2023 Financial Results

28 Feb 2024 13:01:00 By Nasdaq GlobeNewswire

Standard BioTools and Next Gen Diagnostics Announce Partnership to Provide Complete Automation of Low-Cost Pathogen Sequencing

26 Feb 2024 05:00:00 By Nasdaq GlobeNewswire

Standard BioTools to Participate in Upcoming Investor Conferences

22 Feb 2024 13:05:00 By Nasdaq GlobeNewswire

Standard BioTools Announces Conference Call and Webcast for Fourth Quarter and Full Year 2023 Financial Results on February 28, 2024

14 Feb 2024 05:30:00 By Nasdaq GlobeNewswire

Standard BioTools and Navignostics Announce Collaboration Agreement to Advance Imaging Capabilities in Personalized Medicine

07 Feb 2024 05:30:35 By Nasdaq GlobeNewswire

Standard BioTools Announces Preliminary Fourth Quarter and Full Year 2023 Revenue

08 Jan 2024 05:30:32 By Nasdaq GlobeNewswire

Standard BioTools Completes Merger with SomaLogic, Creating a Diversified and Scaled Leader in Life Sciences Tools

05 Jan 2024 05:46:55 By Nasdaq GlobeNewswire

Standard BioTools Stockholders Approve Merger with SomaLogic

04 Jan 2024 19:23:06 By Nasdaq GlobeNewswire

Glass Lewis Recommends Standard BioTools Stockholders Vote “FOR” All Proposals Relating to Proposed Merger with SomaLogic

29 Dec 2023 14:04:12 By Nasdaq GlobeNewswire

ISS Recommends Standard BioTools Stockholders Vote “FOR” All Proposals Relating to Proposed Merger with SomaLogic

22 Dec 2023 15:57:33 By Nasdaq GlobeNewswire